leisure time -WSS

leisure time

author：comprehensive 2025-10-01 21:09:12 - browse：73

ANDREW YATES/AFP via Getty Images

In patients with stage 3 lung cancer where a particular genetic mutation is present in the tumor, taking AstraZeneca’s cancer-fighting pill Tagrisso reduced the chance that disease would progress by 84%.

“This will be practice changing as soon as this becomes available,” said David R. Spigel, chief scientific officer of the Sarah Cannon Research Institute at a press conference announcing the results at the annual meeting of the American Society of Clinical Oncology. “This will be how patients are treated wherever they can get access to this drug.”

Spigel but was not involved in the Tagrisso study but has relationships with multiple drugmakers including AstraZeneca.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Chamber of Commerce, DOJ clash in court over drug prices

focus

Wikipedia

WSS

Woodcock on FDA’s accelerated approval and her next chapter

House panel takes first step toward fixing drug shortages

Do digital therapeutics have a future in medicine?

Time to name cancers by genetics, not organ of origin, expert says

Quicker fix for pulse oximeters urged during FDA public meeting

What we need to know about Arena Bioworks

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

leisure time

Peter Hotez and the public health issue of online harassment

Why the drug industry's warnings on the IRA's impact fall short

Trump demands the U.S. pay no more for drugs than other countries … again

David Liu startup to focus on CRISPR delivery

As demand for Covid shots wanes, Moderna seeks its next success

Eli Lilly CEO gives to Mike Pence presidential super PAC

At least 13 dead in Texas as scorching temps continue

Assistant physicians can help address the primary care shortage

The cancer drug shortage isn’t new — and neither are the solutions

What happened to the House vote on health price transparency?

focus

Medicare drug price negotiation’s day in court

David Liu startup to focus on CRISPR delivery

SAMSHA loosens regulations on methadone treatment centers

Free Covid tests will again be offered to all U.S. households

Biden administration opens offers in Medicare drug price negotiations

Time to name cancers by genetics, not organ of origin, expert says

hotspot

focus

Wikipedia

knowledge